Novel and emerging treatments for autism spectrum disorders: A systematic review

Background: Currently, only one medication (risperidone) is FDA- approved for the treatment of autism spectrum disorders (ASD). Perhaps for this reason, the use of novel, unconventional, and off-label treatments for ASD is common, with up to 74% of children with ASD using these treatments; however, treating physicians are often unaware of this usage.

Purchase this article:

PURCHASE FOR $12

For unlimited access to all issues and articles: